-
Consider Immunotherapy Before Surgery for MelanomaImmunotherapy before surgery is proving to be an effective treatment against melanoma.
by Sandra Gordon
-
An Evidence-Based Guide to Integrative MedicineASCO and the Society for Integrative Oncology issue recommendations for integrative medicine approaches that have been supported with research.
by Teresa Bergen
-
Comparing Costs of At-Home Colorectal Screening TestsCologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard.
by Jon Kelvey
-
A Personal Journey of Thyroid Cancer TreatmentThe practical side of cancer treatment and life without a thyroid.
by Carly Flumer
-
Women Less Satisfied With Cancer CareCompared with men, women’s initial cancer symptoms are less likely to be taken seriously.
by Sandra Gordon
-
2022: The Year in Cancer NewsThe Cancer Today editorial staff selects some of the most impactful reporting and essays of 2022.
by Cancer Today Staff
-
Cancer Today Editors’ Picks: 2022The editors share some of the top stories reported in Cancer Today in the past year.
-
My Name is Mom. And I Have Cancer.Author Tara Rolle shares the challenge of staying fully present as a parent during cancer treatment and in the years that followed.
by Tara Rolle
-
Capivasertib Extends Progression-Free Survival in Hormone Receptor-Positive Breast CancerThe new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
by Eric Fitzsimmons
-
Pregnancy After a Breast Cancer DiagnosisStudy finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
by Thomas Celona
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
